Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.32

+2.7%

Jan 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	3/15/2002 5:37:19 AM
From: nigel bates	Read Replies (1) of 52153

Genomeweb story on proposed legislation which could have significant impact on genomic IP - ...Specifically, if passed, the act would "exempt from patent infringement [those] individuals who use patented genetic sequence information for non-commercial research purposes." Broadly, the act, introduced on Thursday, defines research as a "systematic investigation designed to develop or contribute to generalizable knowledge." The act further exempts "medical practitioners" who use genomic-based diagnostic tests. It defines "genetic diagnostic, prognostic, or predictive test" as "any test designed to detect disease, to predict the potential for a medical disorder, or to predict the effectiveness of therapeutics which use either human or human pathogen genetic sequence information or the proteins encoded by such information."... genomeweb.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next